Get the Stockscreener App
0.4356
6.90%
-0.0323
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.4356, with a volume of 1.75M.
It is down -6.90% in the last 24 hours and up +17.92% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.4679
Open:
$0.4617
24h Volume:
1.75M
Relative Volume:
0.93
Market Cap:
$20.91M
Revenue:
-
Net Income/Loss:
$-37.65M
P/E Ratio:
-0.2608
EPS:
-1.67
Net Cash Flow:
$-24.14M
1W Performance:
-7.61%
1M Performance:
+17.92%
6M Performance:
-76.95%
1Y Performance:
-59.29%
1-Day Range:
$0.4244
$0.4617
1-Week Range:
$0.4244
$0.532
52-Week Range:
$0.30
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.4356 | 31.82M | 0 | -37.65M | -24.14M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
How volatile is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock compared to the marketSmart Portfolio Data Feed For 2025 - jammulinksnews.com
Is Reviva Pharmaceuticals Holdings Inc. a growth stock or a value stockDaily Trading Opportunities For Fast Growth - jammulinksnews.com
What are the technical indicators suggesting about Reviva Pharmaceuticals Holdings Inc.AI Powered Target Finder For Consistent Profits - jammulinksnews.com
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant Outperform Peers After Recent PullbackDaily Smart Money Movement Monitor Activated - beatles.ru
Published on: 2025-07-29 04:00:41 - metal.it
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs during market volatilityConservative Entry for High Return Setup Backed - metal.it
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant a growth stock or a value stockWealth Building Opportunities For Beginners - jammulinksnews.com
How strong is Reviva Pharmaceuticals Holdings Inc. company’s balance sheetMarket-leading profit generation - jammulinksnews.com
What makes Reviva Pharmaceuticals Holdings Inc. stock price move sharplyBreakout Stocks Signals Backed By Experts - jammulinksnews.com
Why Reviva Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionLow Volatility Stable Growth Picks Rank High - metal.it
Is it the right time to buy Reviva Pharmaceuticals Holdings Inc. stockFinancial News Opportunities That Work - jammulinksnews.com
How does Reviva Pharmaceuticals Holdings Inc. Equity Warrant generate profit in a changing economyExplosive capital appreciation - jammulinksnews.com
What institutional investors are buying Reviva Pharmaceuticals Holdings Inc. stockExceptional gains - jammulinksnews.com
What are Reviva Pharmaceuticals Holdings Inc. company’s key revenue driversDiscover breakthrough stocks before the crowd - jammulinksnews.com
New Product Launches: Will They Boost Reviva Pharmaceuticals Holdings Inc. Stock in 2025Proven Return Strategy Execution - metal.it
What is the risk reward ratio of investing in Reviva Pharmaceuticals Holdings Inc. stockDiscover the fastest growing stocks today - jammulinksnews.com
What are Reviva Pharmaceuticals Holdings Inc. Equity Warrant company’s key revenue driversMarket-crushing profits - jammulinksnews.com
How many analysts rate Reviva Pharmaceuticals Holdings Inc. Equity Warrant as a “Buy”Proven strategies for superior portfolio growth - jammulinksnews.com
Published on: 2025-07-28 02:35:06 - jammulinksnews.com
Why is Reviva Pharmaceuticals Holdings Inc. stock attracting strong analyst attentionExceptional return forecasts - jammulinksnews.com
What are the latest earnings results for Reviva Pharmaceuticals Holdings Inc.Unlock powerful stock screening tools today - jammulinksnews.com
What makes Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock price move sharplyStrategic High Profit Opportunities - Newser
Can Reviva Pharmaceuticals Holdings Inc. stock recover from recent declineFree Discussion Group - Newser
Why Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock attracts strong analyst attentionMassive Upside Selection - metal.it
Reviva Pharmaceuticals Holdings Inc. Equity Warrant Stock Analysis and ForecastDouble-digit growth - PrintWeekIndia
What analysts say about Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockFree Stock Market Return Analysis - PrintWeekIndia
What drives Reviva Pharmaceuticals Holdings Inc. stock priceFree Investment Community - PrintWeekIndia
Reviva Pharmaceuticals Holdings Inc. Stock Analysis and ForecastFree Investment Community - PrintWeekIndia
What analysts say about Reviva Pharmaceuticals Holdings Inc. stockOutstanding capital returns - PrintWeekIndia
What drives Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock priceExplosive capital appreciation - PrintWeekIndia
Why Reviva Pharmaceuticals Holdings Inc. stock is on top investor watchlistsTremendous gains - jammulinksnews.com
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):